£156.39

Humana High-Grade Gliomas: Diagnosis and Treatment (Current Clinical Oncology)

Price data last checked 92 day(s) ago - refreshing...

View at Amazon

We'll watch every seller, every day. One email when your price arrives.

This is the most expensive it has ever been. Walk away.

£156 today · previous high £156 · all-time low £153

NEW HERE?

Amazon shows you one price. We show you all of them.

Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.

WHAT'S ON THIS PAGE

↓ Price chart
when this has been cheap or pricey
↓ Forecast
where the price is heading next
↓ Statistics
all-time high & low, recent range
↑ Price alert
name your number, we'll email you

Price History & Forecast

Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.

Last 639 days • 639 data points (No recent data available)

Historical
Generating forecast...
£156.39 £152.53 £153.37 £154.21 £155.06 £155.90 £156.74 09 June 2024 15 November 2024 24 April 2025 30 September 2025 09 March 2026

Price Distribution

Price distribution over 639 days • 2 price levels

Days at Price
Current Price
190 days 449 days · current 0 112 225 337 449 £153 £156 Days at Price

Price Analysis

Most common price: £156 (449 days, 70.3%)

Price range: £153 - £156

Price levels: 2 different prices over 639 days

Description

This is truly an exciting time in the field of neuro-oncology, particularly in the area of hi- grade gliomas. The management of patients with high-grade gliomas has historically been one of the most challenging and disheartening fields in medicine, where failure is the rule and longevity is the exception. The jaded often state that despite purported advances in surgical and radiotherapeutic techniques and a myriad of clinical trials of medical therapies, the s- vival statistics for glioblastoma have not changed in the last three decades. The nihilism associated with these tumors is such that some practitioners still advise against treatment or even biopsy, recommending palliative care with the diagnosis based only on history and an MRI scan. If the current state-of-the-art in the diagnosis and management of high-grade gliomas was truly so bleak, there would be no reason to compile and publish a monograph on the subject. The fact is that we have recently entered an era where real progress is being made in our understanding and treatment of high-grade gliomas that is directly benefiting some patients. We are slowly but surely chipping away at this problem. One approach has exploited correlations between particular molecular markers and therapeutic response. The first such “breakthrough” in high-grade glioma was the observation that loss of chromosomes 1p and 19q uniformly predict chemosensitivity in anaplastic oligodendrogliomas (1).

Product Specifications

Brand
Humana
Format
Paperback
Domain
Amazon UK
Release Date
09 December 2010
Listed Since
11 July 2010

Barcode

No barcode data available

Similar Products You Might Like

Humana High-Grade Gliomas: Diagnosis and Treatment Book
99% match

Humana High-Grade Gliomas: Diagnosis and Treatment Book

Humana

£34.33 26 Feb 2026
Tumors of the Central Nervous System, Volume 1: Gliomas: Glioblastoma (Part 1)
98% match

Tumors of the Central Nervous System, Volume 1: Gliomas: Glioblastoma (Part 1)

Springer

£142.76 01 Apr 2026
The Glioma Book
97% match

The Glioma Book

Thieme

£127.45 13 Jan 2026
Tumors of the Central Nervous System, Volume 1: Gliomas: Glioblastoma (Part 1)
97% match

Tumors of the Central Nervous System, Volume 1: Gliomas: Glioblastoma (Part 1)

Springer

£107.32 13 Jan 2026
Glioblastoma, Part I: Surgical Management and Adjuncts, An Issue of Neurosurgery Clinics of North America: Volume 32-1 (The Clinics: Surgery, Volume 32-1)
97% match

Glioblastoma, Part I: Surgical Management and Adjuncts, An Issue of Neurosurgery Clinics of North America: Volume 32-1 (The Clinics: Surgery, Volume 32-1)

Elsevier

£85.79 10 Apr 2026
Precision Molecular Pathology of Glioblastoma (Molecular Pathology Library)
97% match

Precision Molecular Pathology of Glioblastoma (Molecular Pathology Library)

Springer

£76.81 05 Mar 2026
Glioblastoma:: Molecular Mechanisms of Pathogenesis and Current Therapeutic Strategies
97% match

Glioblastoma:: Molecular Mechanisms of Pathogenesis and Current Therapeutic Strategies

Springer

£147.07 12 Jan 2026
Precision Molecular Pathology of Glioblastoma (Molecular Pathology Library)
97% match

Precision Molecular Pathology of Glioblastoma (Molecular Pathology Library)

£67.04 12 Jan 2026
New Techniques for Management of ‘Inoperable’ Gliomas
97% match

New Techniques for Management of ‘Inoperable’ Gliomas

Academic Press

£100.98 02 Mar 2026
Primary Central Nervous System Tumors: Pathogenesis and Therapy (Current Clinical Oncology)
97% match

Primary Central Nervous System Tumors: Pathogenesis and Therapy (Current Clinical Oncology)

Humana

£124.65 30 Mar 2026
Glioblastoma, Part II: Molecular Targets and Clinical Trials, An Issue of Neurosurgery Clinics of North America: Volume 32-2 (The Clinics: Surgery, Volume 32-2)
97% match

Glioblastoma, Part II: Molecular Targets and Clinical Trials, An Issue of Neurosurgery Clinics of North America: Volume 32-2 (The Clinics: Surgery, Volume 32-2)

Elsevier

£89.59 19 Apr 2026
Biology of Brain Tumour: Proceedings of the Second International Symposium on Biology of Brain Tumour (London, October 24–26, 1984)
97% match

Biology of Brain Tumour: Proceedings of the Second International Symposium on Biology of Brain Tumour (London, October 24–26, 1984)

Springer

£213.13 06 Feb 2026
Glioblastoma:: Molecular Mechanisms of Pathogenesis and Current Therapeutic Strategies
97% match

Glioblastoma:: Molecular Mechanisms of Pathogenesis and Current Therapeutic Strategies

Springer

£141.86 16 Apr 2026
Biology of Brain Tumour: Proceedings of the Second International Symposium on Biology of Brain Tumour (London, October 24–26, 1984)
97% match

Biology of Brain Tumour: Proceedings of the Second International Symposium on Biology of Brain Tumour (London, October 24–26, 1984)

Springer

£247.73 05 Feb 2026
Gliomas: Symptoms, Diagnosis & Treatment Options (Cancer Etiology, Diagnosis and Treatments)
97% match

Gliomas: Symptoms, Diagnosis & Treatment Options (Cancer Etiology, Diagnosis and Treatments)

£120.15 13 Jan 2026
Advances and Technical Standards in Neurosurgery, Vol. 35: Low-Grade Gliomas. Edited by J. Schramm
97% match

Advances and Technical Standards in Neurosurgery, Vol. 35: Low-Grade Gliomas. Edited by J. Schramm

Springer

£162.41 12 Jan 2026
Glioblastoma
97% match

Glioblastoma

MDPI AG

£95.47 07 Mar 2026
Low-Grade Glioma, An Issue of Neurosurgery Clinics of North America (Volume 30-1) (The Clinics: Surgery, Volume 30-1)
97% match

Low-Grade Glioma, An Issue of Neurosurgery Clinics of North America (Volume 30-1) (The Clinics: Surgery, Volume 30-1)

Elsevier

£91.74 08 Mar 2026
Malignant Brain Tumors: State-of-the-Art Treatment
97% match

Malignant Brain Tumors: State-of-the-Art Treatment

Springer

£92.38 25 Feb 2026
Glioblastoma
97% match

Glioblastoma

Elsevier

£75.29 08 Jan 2026
Glioma Imaging: Physiologic, Metabolic, and Molecular Approaches
97% match

Glioma Imaging: Physiologic, Metabolic, and Molecular Approaches

Springer

£61.16 08 Mar 2026
Glioma Imaging: Physiologic, Metabolic, and Molecular Approaches
97% match

Glioma Imaging: Physiologic, Metabolic, and Molecular Approaches

Springer

£87.30 07 Mar 2026
Tumors of the Central Nervous System, Volume 4: Brain Tumors (Part 2)
97% match

Tumors of the Central Nervous System, Volume 4: Brain Tumors (Part 2)

Springer

£147.91 10 Mar 2026
Tumors of the Central Nervous System, Volume 4: Brain Tumors (Part 2)
97% match

Tumors of the Central Nervous System, Volume 4: Brain Tumors (Part 2)

Springer

£117.56 12 Jan 2026